Sughrue Post Grant Expert, John Callahan, to present at Biosimilars conference in Munich

This year’s developments in the Biosimilars industry demonstrate that the time for hesitation has passed and that innovators must have a plan for entering the U.S. Biosimilars market. Join partner John Callahan at this year’s U.S. Biosimilar’s conference in Munich. This flagship conference is a must see for EU companies who plan on doing business in the U.S.

John Callahan will lend his expertise in one of the most watched areas of patent procedures – Post Grant Review – which go directly to the heart of a patent validity challenge. The conference will be held at the Sheraton Munich on April 21, 2015.  For more information on the Biosimilars conference, please click here.